UMR CNRS 5558 Laboratoire de Biométrie et Biologie Évolutive

article :
Van Ganse E, Belhassen M, Ginoux M, Chrétien E, Cornu C, Ecoffey C, Aubrun F (2018)
Use of analgesics in France following dextropropoxyphene withdrawal, BMC health services research, vol. 18 pp.231-231.

Van Ganse E, Texier N, Dima AL, Laforest L, Ferrer M, Hernandez G, Schuck S, Herbage S, Vial D, de Bruin M (2015)
Assessment of the safety of long-acting beta2-agonists in routine asthma care: the ASTRO-LAB protocol, NPJ primary care respiratory medicine, vol. 25 pp.15040-15040.

Caillet P, Souberbielle J C, Jaglal S B, Reymondier A, Van Ganse E, Chapurlat R, Schott A M (2013)
Vitamin D supplementation in a healthy middle-aged population: actual practices based on data from a French comprehensive regional health-care database, European journal of clinical nutrition, vol. 67 pp.1133-7.

Garin O, Ferrer M, Pont A, Wiklund I, Van Ganse E, Vilagut G, Almansa J, Ribera A, Alonso J (2013)
Evidence on the global measurement model of the Minnesota Living with Heart Failure Questionnaire, Quality of life research, vol. 22 pp.2675-2684.

Laforest L, Licaj I, Devouassoux G, Hartwig S, Marvalin S, Van Ganse E (2013)
Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease, Chronic respiratory disease, vol. 10 pp.11-18.

Désaméricq G, Van Ganse E, Schwalm MS, Bourke A, Moulin P (2012)
Severe hypertriglceridaemia in patients treated with lipid-modifying agents, Diabetes & Metabolism, vol. 38 pp.276-279.

Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E (2012)
Mixed dyslipidemias in primary care patients in France, Vasc Health Risk Manag, vol. 8 pp.247-254.

Lenoir-Wijnkoop I, Nuijten M J, Gutierrez-Ibarluzea I, Hutton J, Poley MJ, Segal L, Bresson JL, Van Ganse E, Jones P, Moreno L, Salminen S, Dubois D (2012)
Workshop Report: concepts and methods in the economics of nutrition--gateways to better economic evaluation of nutrition interventions, British Journal of Nutrition, vol. 108 pp.1714-20.

Van Ganse E, Letrilliart L, Borne H, Morand F, Robain M, Siegrist CA (2012)
Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination program, Pharmacoepidemiol and Drug Safety, vol. 21 pp.261-268.

Gouin-Thibault I, Liard F, Van-Ganse E, Vespa L, Gaudin A F, Nachit-Ouinekh F (2011)
Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study, Presse Med, vol. 40 pp.e365-75.

Laforest L, Com-Ruelle L, Broquet M, Devouassoux G, Van Ganse E (2011)
Coût de l`asthme en France, La revue du praticien, vol. pp.40-42.

Lenoir-Wijnkoop I, Dapoigny M, Dubois D, Van Ganse E, Gutierrez-Ibarluzea I, Hutton J, Jones P, Mittendorf T, Poley MJ, Salminen S, Nuijten MJ (2011)
Nutrition economics - characterising the economic and health impact of nutrition, British Journal of Nutrition, vol. 105 pp.157-166.

Laforest L, Denis F, Van Ganse E, Ritleng C, Saussier C, Passante N, Devouassoux G, Chatte G, Freymond N, Pacheco Y (2010)
Correlates of adherence to respiratory drugs in COPD patients, Primary care respiratory journal, vol. 19 pp.148-154.

Sermet C, Andrieu V, Godman B, Van Ganse E, Haycox A, Reynier JP (2010)
Ongoing Pharmaceutical Reforms in France, Applied Health Economics and Health Policy, vol. 8 pp.7-24.

Bousquet PJ, Demoly P, Romano A, Aberer W, Bircher A, Blanca M, Brockow K, Pichler W, Torres MJ, Terreehorst I, Arnoux B, Atanaskovic-Markovic M, Barbaud A, Bijl A, Bonadonna P, Burney P G, Caimmi S, Canonica GW, Cernadas J, Dahlen B, Daures JP, Fernandez J, Gomes EL, Gueant JL, Kowalski ML, Kvedariene V, Mertes PM, Martins P, Nizankowska-Mogilnicka E, Papadopoulos N, Ponvert C, Pirmohamed M, Ring J, Salapatas M, Sanz ML, Szczeklik A, Van Ganse E, De Weck AL, Zuberbier T, Merk HF, Sachs B, Sidoroff A (2009)
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project, Allergy, vol. 64 pp.194-203.

Debouverie M, Laforest L, Van Ganse E, Guillemin F (2009)
Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients, Multiple Sclerosis, vol. 15 pp.251-257.

Desamericq G, Revol A, Laforest L, Chamba G, Bauguil G, Ritleng C, Van Ganse E (2009)
Migraine or headache management: a pharmacy survey, Thérapie, vol. 64 pp.395-403.

Garin O, Ferrer M, Pont A, Rue M, Kotzeva A, Wiklund I, Van Ganse E, Alonso J (2009)
Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses, Qual Life Res, vol. 18 pp.71-85.

Laforest L, El Hasnaoui A, Pribil C, Ritleng C, Osman LM, Schwalm MS, Le Jeunne P, Van Ganse E (2009)
Asthma patients` self-reported behaviours toward inhaled corticosteroids, Respir Med, vol. 103 pp.1366-1375.

Laforest L, Souchet T, Moulin P, Ritleng C, Desamericq G, Le Jeunne P, Schwalm MS, Van Ganse E (2009)
Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs, Archives of Cardiovascular Diseases, vol. 102 pp.43-50.

Laforest L, Van Ganse E, Ritleng C, Desamericq G, Letrilliart L, Moreau A, Rosen S, Mechin H, Chamba G (2009)
Correlates of quality of life of pre-obese and obese patients: a pharmacy-based cross-sectional survey, BMC Public Health, vol. 9 pp.337-337.

Devouassoux G, Pachot A, Laforest L, Diasparra J, Freymond N, Van Ganse E, Mougin B, Pacheco Y (2008)
Galectin-10 mRNA is overexpressed in peripheral blood of aspirin-induced asthma, Allergy, vol. 63 pp.125-131.

Laforest L, Com-Ruelle L, Devouassoux G, Pison C, Van Ganse E (2008)
Economic aspects of severe asthma, Presse Med, vol. 37 pp.117-28.

Laforest L, Moulin P, Souchet T, Ritleng C, Desamericq G, Le Jeunne P, Schwalm MS, Kieffer A, Van Ganse E (2008)
Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy, Atherosclerosis, vol. 199 pp.368-377.

Laforest L, Van Ganse E, Devouassoux G, El Hasnaoui A, Osman L M, Bauguil G, Chamba G (2008)
Dispensing of antibiotics antitussives and mucolytics to asthma patients: a pharmacy-based observational survey, Respir Med, vol. 102 pp.57-63.

Laforest L, Moulin P, Schwalm M , Le Jeunne P, Chretin S, Kitio B, Massol J, Van Ganse E (2007)
Use of margarine enriched in phytosterols by patients at high cardiovascular risk and treated by hypolipidemic drugs, Nutr Metab Cardiovasc Dis, vol. 17 pp.657-665.

Laforest L, Van Ganse E, Devouassoux G, Osman LM, Bauguil G, Chamba G (2007)
Patient-reported Adverse Events Under Asthma Therapy: A Community Pharmacy-based Survey, Clinical Pharmacology and Therapeutics, vol. 82 pp.167-172.

Laforest L, Van Ganse E, Devouassoux G, Osman LM, Brice K, Massol J, Bauguil G, Chamba G (2007)
Asthmatic patients` poor awareness of inadequate disease control: a pharmacy-based survey, ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, vol. 98 pp.146-152.

Roze S, Ferrieres J, Bruckert E, Van Ganse E, Chapman MJ, Liens D, Renaudin C (2007)
Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective, Int J Clin Pract, vol. 61 pp.1805-1811.

Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T (2007)
Mixed Dyslipidemia Among Patients Using Lipid-Lowering Therapy in French General Practice: An Observational Study, Clinical Therapeutics, vol. 29 pp.1671-1681.

Fantino B, Voirin N, Laforest L , Fantino F, Chretin S, Van Ganse E (2006)
Primary care physicians` behaviors towards risk of iatrogenesis in elderly patients, European Journal of Clinical Pharmacology, vol. 62 pp.563-570.